Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Cancers
|
April 3, 2021
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Critical Reviews in Oncology/Hematology
|
May 7, 2018
When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
Stefania Gori, Monica Turazza, Alessandra Modena, et al.
The Oncologist
|
December 15, 2015
Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives
Alessandro Inno, Giuseppe Bogina, Monica Turazza, et al.
Cancers
|
February 25, 2022
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years
Rosa Falcone, Pasquale Lombardi, Marco Filetti, et al.
Cancers
|
May 14, 2022
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives
Paola Fuso, Margherita Muratore, Tatiana D'Angelo, et al.
Cancers
|
March 11, 2023
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
Ilaria Capasso, Angela Santoro, Emanuela Lucci Cordisco, et al.
International Journal of Molecular Sciences
|
June 13, 2025
A Case Report to Reflect on the Origins of MMRd Mesonephric-like Ovarian Adenocarcinoma: Can It Be Defined as a Mϋllerian Neoplasm?
Nicoletta D'Alessandris, Angela Santoro, Michele Valente, et al.
Cancers
|
October 23, 2021
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
Simona Duranti, Alessandra Fabi, Marco Filetti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2012
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype
Giulio Metro, Rita Chiari, Simona Duranti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 19, 2026
Co-targeting hallmarks of cancer for therapeutic benefit in ovarian cancer: a scoping review
Valentina Iacobelli, Floriana Camarda, Gloria Anderson, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Cancers
|
April 3, 2021
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Critical Reviews in Oncology/Hematology
|
May 7, 2018
When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
Stefania Gori, Monica Turazza, Alessandra Modena, et al.
The Oncologist
|
December 15, 2015
Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives
Alessandro Inno, Giuseppe Bogina, Monica Turazza, et al.
Cancers
|
February 25, 2022
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years
Rosa Falcone, Pasquale Lombardi, Marco Filetti, et al.
Cancers
|
May 14, 2022
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives
Paola Fuso, Margherita Muratore, Tatiana D'Angelo, et al.
Cancers
|
March 11, 2023
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
Ilaria Capasso, Angela Santoro, Emanuela Lucci Cordisco, et al.
International Journal of Molecular Sciences
|
June 13, 2025
A Case Report to Reflect on the Origins of MMRd Mesonephric-like Ovarian Adenocarcinoma: Can It Be Defined as a Mϋllerian Neoplasm?
Nicoletta D'Alessandris, Angela Santoro, Michele Valente, et al.
Cancers
|
October 23, 2021
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
Simona Duranti, Alessandra Fabi, Marco Filetti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2012
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype
Giulio Metro, Rita Chiari, Simona Duranti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 19, 2026
Co-targeting hallmarks of cancer for therapeutic benefit in ovarian cancer: a scoping review
Valentina Iacobelli, Floriana Camarda, Gloria Anderson, et al.
Page
of 4